272 related articles for article (PubMed ID: 28715615)
1. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for
Seibold U; Wängler B; Wängler C
ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of
Rousseau J; Zhang Z; Dias GM; Zhang C; Colpo N; Bénard F; Lin KS
Bioorg Med Chem Lett; 2017 Feb; 27(4):708-712. PubMed ID: 28131709
[TBL] [Abstract][Full Text] [Related]
3. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
Zhai C; He S; Ye Y; Rangger C; Kaeopookum P; Summer D; Haas H; Kremser L; Lindner H; Foster J; Sosabowski J; Decristoforo C
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845658
[TBL] [Abstract][Full Text] [Related]
4. Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).
Guérard F; Lee YS; Brechbiel MW
Chemistry; 2014 May; 20(19):5584-91. PubMed ID: 24740517
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry.
Salih AK; Raheem SJ; Garcia MD; Ahiahonu WK; Price EW
Inorg Chem; 2022 Dec; 61(51):20964-20976. PubMed ID: 36516446
[TBL] [Abstract][Full Text] [Related]
6. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals.
Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW
Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491
[TBL] [Abstract][Full Text] [Related]
7. Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.
Pandya DN; Pailloux S; Tatum D; Magda D; Wadas TJ
Chem Commun (Camb); 2015 Feb; 51(12):2301-3. PubMed ID: 25556851
[TBL] [Abstract][Full Text] [Related]
8. Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: implications in new chelate design.
Holland JP; Vasdev N
Dalton Trans; 2014 Jul; 43(26):9872-84. PubMed ID: 24722728
[TBL] [Abstract][Full Text] [Related]
9. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of bifunctional tetrahydroxamate chelators for labeling antibodies with
Rousseau J; Zhang Z; Wang X; Zhang C; Lau J; Rousseau E; Čolović M; Hundal-Jabal N; Bénard F; Lin KS
Bioorg Med Chem Lett; 2018 Mar; 28(5):899-905. PubMed ID: 29426769
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
12. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.
Sarbisheh EK; Salih AK; Raheem SJ; Lewis JS; Price EW
Inorg Chem; 2020 Aug; 59(16):11715-11727. PubMed ID: 32799484
[TBL] [Abstract][Full Text] [Related]
13. Cyclic versus Noncyclic Chelating Scaffold for
Summer D; Garousi J; Oroujeni M; Mitran B; Andersson KG; Vorobyeva A; Löfblom J; Orlova A; Tolmachev V; Decristoforo C
Mol Pharm; 2018 Jan; 15(1):175-185. PubMed ID: 29160082
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging.
Guérard F; Lee YS; Tripier R; Szajek LP; Deschamps JR; Brechbiel MW
Chem Commun (Camb); 2013 Feb; 49(10):1002-4. PubMed ID: 23250287
[TBL] [Abstract][Full Text] [Related]
15. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
Deri MA; Ponnala S; Zeglis BM; Pohl G; Dannenberg JJ; Lewis JS; Francesconi LC
J Med Chem; 2014 Jun; 57(11):4849-60. PubMed ID: 24814511
[TBL] [Abstract][Full Text] [Related]
16. Predicting the Thermodynamic Stability of Zirconium Radiotracers.
Holland JP
Inorg Chem; 2020 Feb; 59(3):2070-2082. PubMed ID: 31940188
[TBL] [Abstract][Full Text] [Related]
17. An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes.
Patra M; Bauman A; Mari C; Fischer CA; Blacque O; Häussinger D; Gasser G; Mindt TL
Chem Commun (Camb); 2014 Oct; 50(78):11523-5. PubMed ID: 25132321
[TBL] [Abstract][Full Text] [Related]
18. Side-by-Side Comparison of Five Chelators for
Damerow H; Hübner R; Judmann B; Schirrmacher R; Wängler B; Fricker G; Wängler C
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944969
[TBL] [Abstract][Full Text] [Related]
19. Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates.
Zhai C; Summer D; Rangger C; Franssen GM; Laverman P; Haas H; Petrik M; Haubner R; Decristoforo C
Mol Pharm; 2015 Jun; 12(6):2142-50. PubMed ID: 25941834
[TBL] [Abstract][Full Text] [Related]
20. Tales of the Unexpected: The Case of Zirconium(IV) Complexes with Desferrioxamine.
Savastano M; Bazzicalupi C; Ferraro G; Fratini E; Gratteri P; Bianchi A
Molecules; 2019 Jun; 24(11):. PubMed ID: 31159506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
